Quadrisol

RSS

vedaprofen

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Quadrisol. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Quadrisol.

For practical information about using Quadrisol, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 24/08/2017

Authorisation details

Product details
Name
Quadrisol
Agency product number
EMEA/V/C/000032
Active substance
vedaprofen
International non-proprietary name (INN) or common name
vedaprofen
Species
Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AE90
Publication details
Marketing-authorisation holder
VETCOOL B.V.
Revision
18
Date of issue of marketing authorisation valid throughout the European Union
04/12/1997
Contact address
Otto Hahnweg 24
3542 AX Utrecht
Netherlands

Product information

25/04/2017 Quadrisol - EMEA/V/C/000032 - T/0037

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Not yet assigned

Therapeutic indication

Reduction of inflammation and relief of pain associated with musculoskeletal disorders and soft-tissue lesions (traumatic injuries and surgical trauma). In cases of anticipated surgical trauma, Quadrisol can be given prophylactically at least three hours prior to elective surgery.

Assessment history

How useful was this page?

Add your rating